<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="320745">
  <stage>Registered</stage>
  <submitdate>29/10/2009</submitdate>
  <approvaldate>4/11/2009</approvaldate>
  <actrnumber>ACTRN12609000948291</actrnumber>
  <trial_identification>
    <studytitle>Randomized clinical trial of the influence of intraperitoneal local anesthesia on pain after laparoscopic colectomy</studytitle>
    <scientifictitle>Randomized clinical trial of the influence of intraperitoneal local anesthesia on pain after laparoscopic colectomy.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>the patients undergoing laparoscopic colectomy</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>There are three groups in total: Group I(infiltration), Group D(Double0, Group C(
Control).
Group I(Infiltration) : infiltration ropivacaine only at the beginning of the surgery 
Group D(Double) : infiltration ropivacaine twice during the surgery (time of start and end of surgery)
Immediately after creation of pneumoperitoneum and place of the first two trocars 1 mg/kg of ropivacaine in 100 ml normal saline in Group I and Group D will be sprayed on the upper surface of right and left lobe of liver and left hemidiaphragm.
At the end of the operation and before withdrawing the first trocar, 100ml normal saline in Group I and 1 mg/kg of ropivacaine in 100 ml normal saline in Group D will be sprayed on the upper surface of right and left lobe of liver and left hemidiaphragm in Group D.
This is one off treatment.</interventions>
    <comparator>Group C(Control) : control group without ropivacaine infiltration , only normal saline 100 ml
Immediately after creation of pneumoperitoneum and place of the first two trocars and at the end of the operation and before withdrawing the first trocar, 100 ml normal saline will be sprayed on the upper surface of right and left lobe of liver and left hemidiaphragm in Group C.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Patients will be assessed for pain using a visual analogue pain scale (VAS) 
A VAS is a measurement instrument that tried to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end;  left side end which represents 0 is 'No pain', right side end with 100 is 'Very severe pain'. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimeters from the left hand end of the line to the point that the patient marks.</outcome>
      <timepoint>at six time intervals after surgery ; 2 h, 4 h, 8 h, 12 h, 24 h , and 48 h</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The opioid consumption of the patients controlled analgesia (PCA) and additional opioid will be assessed</outcome>
      <timepoint>at six time intervals after surgery ; 2 h, 4 h, 8 h, 12 h, 24 h , and 48 h</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>PCM (patient controlled module :Number of attempt patient try to receive analgesics using PCA machine) of the PCA machine will be assessed</outcome>
      <timepoint>at six time intervals after surgery ; 2 h, 4 h, 8 h, 12 h, 24 h , and 48 h</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>nausea and vomiting</outcome>
      <timepoint>anytime after surgery when patient complaint</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients will be scheduled to undergo elective laparoscopic colectomy.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients weigh under 45 kg or over 100 kg,
have severe underlying cardiovascular, renal, hepatic diseases, and have allergy to local anesthetics will be excluded.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>choose the opaque envelope maintain computer-generated code</concealment>
    <sequence>Randomization into one of three groups  will be based using randomized number using excel program.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/12/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Korea, Republic Of</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Chuna-Ang University</primarysponsorname>
    <primarysponsoraddress>221 Heukseok-Dong, Dongjak-Gu, 

Seoul 156-755</primarysponsoraddress>
    <primarysponsorcountry>Korea, Republic Of</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Chuna-Ang University</fundingname>
      <fundingaddress>224-1 Heukseok-Dong, Dongjak-Gu, 

Seoul 156-755</fundingaddress>
      <fundingcountry>Korea, Republic Of</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Chuna-Ang University Hospital</sponsorname>
      <sponsoraddress>224-1 Heukseok-Dong, Dongjak-Gu, 

Seoul 156-755</sponsoraddress>
      <sponsorcountry>Korea, Republic Of</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to examine the effect of intraperitoneal LA on the requirement for postoperative and pain intensity after long duration of pneumoperitoneum. We also hypothesize that the timing of administration of  intraperitoneal local anesthetics(LA) will affect to postoperative pain.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>27/10/2009</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Hyun Kang</name>
      <address>224-1 Heukseok-Dong, Dongjak-Gu, 

Seoul 156-755</address>
      <phone>+82-2-6299-2571</phone>
      <fax>+82-2-6299-2575</fax>
      <email>roman00@naver.com</email>
      <country>Korea, Republic Of</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Hyun Kang</name>
      <address>224-1 Heukseok-Dong, Dongjak-Gu, 

Seoul 156-755</address>
      <phone>+82-2-6299-2571</phone>
      <fax>+82-2-6299-2575</fax>
      <email>roman00@naver.com</email>
      <country>Korea, Republic Of</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Hyun Kang</name>
      <address>224-1 Heukseok-Dong, Dongjak-Gu, 

Seoul 156-755</address>
      <phone>+82-2-6299-2571</phone>
      <fax>+82-2-6299-2575</fax>
      <email>roman00@naver.com</email>
      <country>Korea, Republic Of</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>